Vandooren J, Van den Steen PE, Opdenakker G (2013). "Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade". Critical Reviews in Biochemistry and Molecular Biology. 48 (3): 222–272. doi:10.3109/10409238.2013.770819. PMID23547785. S2CID33781725.
Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G (December 2002). "Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)". Critical Reviews in Biochemistry and Molecular Biology. 37 (6): 375–536. doi:10.1080/10409230290771546. PMID12540195. S2CID35833950.
Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A (March 1996). "Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane". American Journal of Respiratory Cell and Molecular Biology. 14 (3): 288–295. doi:10.1165/ajrcmb.14.3.8845180. PMID8845180.
Tranchant I, Vera L, Czarny B, Amoura M, Cassar E, Beau F, et al. (March 2014). "Halogen bonding controls selectivity of FRET substrate probes for MMP-9". Chemistry & Biology. 21 (3): 408–413. doi:10.1016/j.chembiol.2014.01.008. PMID24583051.
Bode W, Gomis-Rüth FX, Stöckler W (September 1993). "Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'". FEBS Letters. 331 (1–2): 134–140. Bibcode:1993FEBSL.331..134B. doi:10.1016/0014-5793(93)80312-I. PMID8405391. S2CID27244239.
Gomis-Rüth FX, Gohlke U, Betz M, Knäuper V, Murphy G, López-Otín C, et al. (December 1996). "The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain". Journal of Molecular Biology. 264 (3): 556–566. doi:10.1006/jmbi.1996.0661. PMID8969305.
Gruber BL, Sorbi D, French DL, Marchese MJ, Nuovo GJ, Kew RR, et al. (February 1996). "Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker". Clinical Immunology and Immunopathology. 78 (2): 161–171. doi:10.1006/clin.1996.0025. PMID8625558.
Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR (November 1997). "Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia". Neuroscience Letters. 238 (1–2): 53–56. doi:10.1016/s0304-3940(97)00859-8. PMID9464653. S2CID916260.
Messmer EM, von Lindenfels V, Garbe A, Kampik A (November 2016). "Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay". Ophthalmology. 123 (11): 2300–2308. doi:10.1016/j.ophtha.2016.07.028. PMID27665213.
Bode W, Gomis-Rüth FX, Stöckler W (September 1993). "Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'". FEBS Letters. 331 (1–2): 134–140. Bibcode:1993FEBSL.331..134B. doi:10.1016/0014-5793(93)80312-I. PMID8405391. S2CID27244239.
Vandooren J, Van den Steen PE, Opdenakker G (2013). "Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade". Critical Reviews in Biochemistry and Molecular Biology. 48 (3): 222–272. doi:10.3109/10409238.2013.770819. PMID23547785. S2CID33781725.
Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G (December 2002). "Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)". Critical Reviews in Biochemistry and Molecular Biology. 37 (6): 375–536. doi:10.1080/10409230290771546. PMID12540195. S2CID35833950.
Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A (March 1996). "Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane". American Journal of Respiratory Cell and Molecular Biology. 14 (3): 288–295. doi:10.1165/ajrcmb.14.3.8845180. PMID8845180.
Tranchant I, Vera L, Czarny B, Amoura M, Cassar E, Beau F, et al. (March 2014). "Halogen bonding controls selectivity of FRET substrate probes for MMP-9". Chemistry & Biology. 21 (3): 408–413. doi:10.1016/j.chembiol.2014.01.008. PMID24583051.
Bode W, Gomis-Rüth FX, Stöckler W (September 1993). "Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'". FEBS Letters. 331 (1–2): 134–140. Bibcode:1993FEBSL.331..134B. doi:10.1016/0014-5793(93)80312-I. PMID8405391. S2CID27244239.
Gomis-Rüth FX, Gohlke U, Betz M, Knäuper V, Murphy G, López-Otín C, et al. (December 1996). "The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain". Journal of Molecular Biology. 264 (3): 556–566. doi:10.1006/jmbi.1996.0661. PMID8969305.
Gruber BL, Sorbi D, French DL, Marchese MJ, Nuovo GJ, Kew RR, et al. (February 1996). "Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker". Clinical Immunology and Immunopathology. 78 (2): 161–171. doi:10.1006/clin.1996.0025. PMID8625558.
Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR (November 1997). "Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia". Neuroscience Letters. 238 (1–2): 53–56. doi:10.1016/s0304-3940(97)00859-8. PMID9464653. S2CID916260.
Messmer EM, von Lindenfels V, Garbe A, Kampik A (November 2016). "Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay". Ophthalmology. 123 (11): 2300–2308. doi:10.1016/j.ophtha.2016.07.028. PMID27665213.
ncbi.nlm.nih.gov
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Vandooren J, Van den Steen PE, Opdenakker G (2013). "Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade". Critical Reviews in Biochemistry and Molecular Biology. 48 (3): 222–272. doi:10.3109/10409238.2013.770819. PMID23547785. S2CID33781725.
Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G (December 2002). "Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)". Critical Reviews in Biochemistry and Molecular Biology. 37 (6): 375–536. doi:10.1080/10409230290771546. PMID12540195. S2CID35833950.
Bode W, Gomis-Rüth FX, Stöckler W (September 1993). "Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'". FEBS Letters. 331 (1–2): 134–140. Bibcode:1993FEBSL.331..134B. doi:10.1016/0014-5793(93)80312-I. PMID8405391. S2CID27244239.
Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR (November 1997). "Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia". Neuroscience Letters. 238 (1–2): 53–56. doi:10.1016/s0304-3940(97)00859-8. PMID9464653. S2CID916260.